➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Moodys
McKesson
McKinsey
Johnson and Johnson

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FERRIC CARBOXYMALTOSE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Ferric Carboxymaltose

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00548691 Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients Completed Luitpold Pharmaceuticals Phase 3 2007-10-01 The Objective of this study is to study the safety of FCM in patients with anemia caused by chronic kidney failure
NCT00548860 Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients Completed Luitpold Pharmaceuticals Phase 3 2007-10-01 The Objective of this study is to study the safety of FCM in patients with anemia caused by Heavy Uterine Bleeding and the Post Partum state.
NCT00703937 Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia Completed Luitpold Pharmaceuticals Phase 3 2008-07-01 The objective of this study is to evaluate the safety of FCM in patients with anemia who are not dialysis dependent.
NCT00704028 Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia Completed Luitpold Pharmaceuticals Phase 3 2008-06-01 The objective of this study is to evaluate the safety of FCM in patients with anemia who are not dialysis dependent.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Ferric Carboxymaltose

Condition Name

Condition Name for Ferric Carboxymaltose
Intervention Trials
Anemia 21
Iron Deficiency Anemia 17
Iron Deficiency 16
Iron-deficiency 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ferric Carboxymaltose
Intervention Trials
Anemia, Iron-Deficiency 68
Anemia 50
Deficiency Diseases 17
Heart Failure 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ferric Carboxymaltose

Trials by Country

Trials by Country for Ferric Carboxymaltose
Location Trials
United States 59
Germany 23
Spain 14
United Kingdom 8
France 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Ferric Carboxymaltose
Location Trials
Pennsylvania 10
Texas 6
Florida 5
California 5
North Carolina 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ferric Carboxymaltose

Clinical Trial Phase

Clinical Trial Phase for Ferric Carboxymaltose
Clinical Trial Phase Trials
Phase 4 34
Phase 3 40
Phase 2/Phase 3 1
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ferric Carboxymaltose
Clinical Trial Phase Trials
Recruiting 35
Completed 27
Not yet recruiting 26
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ferric Carboxymaltose

Sponsor Name

Sponsor Name for Ferric Carboxymaltose
Sponsor Trials
Luitpold Pharmaceuticals 19
Vifor Inc. 14
Vifor Pharma 10
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ferric Carboxymaltose
Sponsor Trials
Other 99
Industry 67
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Johnson and Johnson
Boehringer Ingelheim
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.